Humana shares dropped sharply this week following a modest Medicare Advantage rate proposal and renewed risk-adjustment scrutiny. The 0.9% proposed rate increase for 2027 and related policy pressures are creating tangible margin risk for Humana, which is heavily exposed to Medicare Advantage enrollment.
